Effect of multi-strain probiotics supplementation on chemotherapy-related side effects among patients with breast cancer: A pilot trial
Open Access
- 14 March 2025
- journal article
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-9
Abstract
This study aimed to identify the effect of a 7-strain probiotics formulation on chemotherapy-related side effects, complete blood counts, blood biochemistry, and Karnofsky performance scores. All patients diagnosed with breast cancer who received chemotherapy at a hospital in Surabaya, Indonesia, were considered eligible to join the study. Before probiotic supplementation, the baseline values of the tested parameters were obtained and later compared with the values after 21–30 days of probiotic supplementation. Multi-strain probiotics supplementation could alleviate the fatigue and nausea symptoms in our patients. Significant improvements were observed after probiotic supplementation compared to before supplementation in the Karnofsky performance scores (median: 100 versus 90, respectively; p < 0.001) and blood urea nitrogen (11.6 mg/dL versus 10.05 mg/dL, respectively; p = 0.008). Non-significant differences were found for the complete blood counts, alanine aminotransferase, and serum creatinine. Our findings provide preliminary evidence about the potential role of multi-strain probiotics supplementation to alleviate chemotherapy-related side effects.Keywords
This publication has 37 references indexed in Scilit:
- Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic ReviewAdvances in Therapy, 2024
- Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?Drugs, 2024
- Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)The Breast, 2023
- Current and future burden of breast cancer: Global statistics for 2020 and 2040The Breast, 2022
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAnnals of Oncology, 2021
- Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitorsEuropean Journal of Cancer, 2018
- The pathophysiology of cancer-related fatigue: current controversiesSupportive Care in Cancer, 2018
- The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumour in a mouse modelImmunobiology, 2014
- Inadequate symptom control in advanced cancer patients across EuropeSupportive Care in Cancer, 2010
- Mitochondrial protein oxidation and degradation in response to oxidative stress and agingExperimental Gerontology, 2006